Courts
Featured

FDA Asks Supreme Court to Reinstate Safety Rule for Abortion Pill

FDA Asks Supreme Court to Reinstate Safety Rule for Abortion Pill
A woman looks at an abortion pill (RU-486) for unintended pregnancy displayed on a smartphone in Arlington, Va., on May 8, 2020. Olivier Douliery/AFP via Getty Images
Matthew Vadum
Matthew Vadum
contributor
|Updated:

The Trump administration is asking the Supreme Court to reinstitute a rule requiring that an abortion-inducing drug be taken in the presence of a medical doctor, after a judge issued a nationwide injunction in July pausing the safety requirement during the current pandemic.

The drug RU486, also known as Mifeprex, is used to end a pregnancy during the first 10 weeks and can cause excessive bleeding, according to the government. Around 85 percent of patients “report at least one adverse reaction” following the use of the drug, the most common being “nausea, weakness, fever/chills, vomiting, headache, diarrhea, and dizziness,” according to studies.